The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of prior radiation on survival in metastatic lung cancer ECOG-ACRIN trials.
 
Saad A. Khan
Honoraria - ARIAD; EMD Serono; Genentech/Roche; Genzyme
Consulting or Advisory Role - ARIAD; EMD Serono; Genentech/Roche
Speakers' Bureau - Genzyme
Research Funding - Abbvie (Inst); Bayer/Onyx (Inst); Celldex (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Novartis
 
Maneka Puligandla
No Relationships to Disclose
 
Suzanne Eleanor Dahlberg
Patents, Royalties, Other Intellectual Property - Patent pending for a statistical model assessing tumor growth (Inst)
 
Gregory A. Masters
No Relationships to Disclose
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst)
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst)
 
Philip Bonomi
No Relationships to Disclose
 
David E. Gerber
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Samsung Bioepis
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - ArQule (Inst); BerGenBio (Inst); ImClone Systems (Inst); Immunogen (Inst); Karyopharm Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Decision Support in Medicine from the Clinical Decision Support--Oncology on-line program.; Royalties from Oxford University Press from two books.
Travel, Accommodations, Expenses - ArQule; Bristol-Myers Squibb; Lilly; Lilly
 
David H. Johnson
Consulting or Advisory Role - miRNA Therapeutics; Peloton Therapeutics; Roche/Genentech
 
Joan H. Schiller
Consulting or Advisory Role - Ariad; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; Genentech/Roche; Lilly; Merck; Oncogenex
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Clovis Oncology (Inst); Genentech (Inst); Synta (Inst); Xcovery (Inst)
Other Relationship - Free to Breathe
 
Suresh S. Ramalingam
No Relationships to Disclose